Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,028 JPY | +0.12% |
|
-2.75% | -0.64% |
06-21 | Takeda Secures European Commission's Approval for Colorectal Cancer Drug Fruzaqla | MT |
06-21 | Takeda Pharmaceutical Gets European Commission Approval for Cancer Treatment | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.64% | 39.61B | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Issues New Shares, Disposes of Treasury Shares Under Long-term Incentive Plan for Employees